This study focuses on inhibition of NTs (TrkB/BDNF) and/or autophagy, which are two survival‐signaling pathways and shows the efficiency of the twin treatment, which largely contribute to reduce tumour growth (Fig. 8). Here, NTRK2 is linked to neoplasm.